Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)

Completed · Phase 4

Conditions studied: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder

In brief

This study is testing if under the tongue olanzapine for schizophrenia, related psychosis, schizoaffective disorder or bipolar disorder will have less weight gain than olanzapine that is swallowed, in patients who are already gaining weight on olanzapine.

Key facts

Study ID
NCT00303602
Run by
Eli Lilly and Company
People needed
149
Starts
2006-03-01
Expected to finish
2007-12-01
Last updated by the study team
2009-06-10

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.